用于体外循环后血管麻痹性休克的合成人血管紧张素II - Suppr

Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.

作者信息

Wieruszewski Patrick M, Radosevich Misty A, Kashani Kianoush B, Daly Richard C, Wittwer Erica D

机构信息

Department of Pharmacy, Mayo Clinic, Rochester, MN; Multidisciplinary Epidemiology and Translational Research in Intensive Care, Mayo Clinic, Rochester, MN.

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.

出版信息

J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3080-3084. doi: 10.1053/j.jvca.2019.03.004. Epub 2019 Mar 8.

DOI:10.1053/j.jvca.2019.03.004

PMID:31060933

Abstract

摘要

相似文献

Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.用于体外循环后血管麻痹性休克的合成人血管紧张素II

J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3080-3084. doi: 10.1053/j.jvca.2019.03.004. Epub 2019 Mar 8.

Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients.评估血管紧张素II用于治疗重症心胸外科手术患者血管麻痹的证据。

J Thorac Cardiovasc Surg. 2022 Apr;163(4):1407-1414. doi: 10.1016/j.jtcvs.2021.02.097. Epub 2021 Mar 19.

[Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].[体外循环心脏手术期间的血管麻痹综合征及其血管加压素治疗]

Rev Med Chil. 2011 Mar;139(3):368-72. Epub 2011 Aug 25.

Factors associated with vasoplegic shock in the postoperative period of cardiac surgery and influence on morbidity and mortality of the use of arginine vasopressin as rescue therapy.心脏手术后并发血管扩张性休克的相关因素及精氨酸加压素作为抢救治疗的应用对发病率和死亡率的影响。

Med Intensiva (Engl Ed). 2024 Jul;48(7):392-402. doi: 10.1016/j.medine.2024.04.003. Epub 2024 May 1.

Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome.血管扩张性休克后使用血管紧张素 II。

Ann Thorac Surg. 2019 Jul;108(1):e5-e7. doi: 10.1016/j.athoracsur.2018.11.047. Epub 2018 Dec 21.

Vasoplegia during cardiac surgery: current concepts and management.心脏手术中的血管麻痹：当前概念与处理。

Semin Thorac Cardiovasc Surg. 2010 Summer;22(2):140-4. doi: 10.1053/j.semtcvs.2010.09.007.

Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.羟钴胺素（维生素 B12a）在体外循环后血管加压药抵抗性低血压患者中的应用：病例系列。

Anesth Analg. 2019 Jul;129(1):e1-e4. doi: 10.1213/ANE.0000000000003648.

Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.心胸外科手术后血管麻痹综合征：病理生理学综述及治疗选择更新。

Crit Care. 2020 Feb 4;24(1):36. doi: 10.1186/s13054-020-2743-8.

Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.血管扩张性休克治疗（ATHOS-3）研究的事后分析：血管扩张性心脏病手术后患者应用血管紧张素 II 治疗与血压快速反应和血管加压素节省相关。

J Cardiothorac Vasc Anesth. 2021 Jan;35(1):51-58. doi: 10.1053/j.jvca.2020.08.001. Epub 2020 Aug 7.

Use of Angiotensin II in Severe Vasoplegia After Left Pneumonectomy Requiring Cardiopulmonary Bypass: A Renin Response Analysis.左肺切除术后需体外循环的严重血管麻痹中血管紧张素 II 的应用：肾素反应分析。

Crit Care Med. 2020 Oct;48(10):e912-e915. doi: 10.1097/CCM.0000000000004502.

引用本文的文献

Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgery.心脏手术后血管麻痹患者血管紧张素 II 给药时机与预后的关系。

JTCVS Open. 2025 Apr 25;25:280-293. doi: 10.1016/j.xjon.2025.04.014. eCollection 2025 Jun.

Angiotensin II as a Vasopressor for Perioperative Hypotension in Solid Organ Transplant.血管紧张素II作为实体器官移植围手术期低血压的血管加压药

Biomedicines. 2024 Aug 9;12(8):1817. doi: 10.3390/biomedicines12081817.

Angiotensin ii therapy in refractory septic shock: which patient can benefit most? A narrative review.难治性感染性休克中的血管紧张素 II 治疗：哪些患者获益最大？一篇叙述性综述。

J Anesth Analg Crit Care. 2024 Feb 21;4(1):13. doi: 10.1186/s44158-024-00150-w.

Angiotensin-II for vasoplegia following cardiac surgery.血管扩张术后应用血管紧张素 II。

Perfusion. 2024 Nov;39(8):1676-1684. doi: 10.1177/02676591231215920. Epub 2023 Nov 13.

Vasoplegic syndrome in patients undergoing heart transplantation.心脏移植患者的血管麻痹综合征

Front Surg. 2023 Feb 13;10:1114438. doi: 10.3389/fsurg.2023.1114438. eCollection 2023.

A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery.血管紧张素-2 在心脏手术中的双盲随机可行性试验。

Anaesthesia. 2022 Sep;77(9):999-1009. doi: 10.1111/anae.15802.

Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: A case series.血管扩张性休克综合征术后使用血管紧张素 II 的结果：病例系列。

Ann Card Anaesth. 2022 Jul-Sep;25(3):359-361. doi: 10.4103/aca.aca_98_21.

Protocol Compliance Guiding Angiotensin II Use in Post Cardiovascular Surgery Vasoplegia.心血管手术后血管麻痹中血管紧张素II使用的方案依从性指导

Crit Care Explor. 2022 May 13;4(5):e0687. doi: 10.1097/CCE.0000000000000687. eCollection 2022 May.

Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass.血管麻痹：体外循环后的机制与管理

Eurasian J Med. 2022 Feb;54(1):92-99. doi: 10.5152/eurasianjmed.2022.20394.

Early Use of Methylene Blue in Vasoplegic Syndrome: A 10-Year Propensity Score-Matched Cohort Study.亚甲蓝在血管麻痹综合征中的早期应用：一项为期10年的倾向评分匹配队列研究。

J Clin Med. 2022 Feb 20;11(4):1121. doi: 10.3390/jcm11041121.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献